OUTCOMES OF INTRAUTERINE TRANSFUSION FOR FETAL ANEMIA: A CASE SERIES AT HANOI OBSTETRICS AND GYNECOLOGY HOSPITAL
Nội dung chính của bài viết
Tóm tắt
Objective: To describe the outcomes of intrauterine transfusion for fetal anemia at Hanoi Obstetrics and Gynecology Hospital.
Materials and Methods: A prospective case series study was conducted on 05 fetuses diagnosed with severe anemia indicated for ultrasound-guided intrauterine transfusion (IUT) at the Fetal Intervention Center, Hanoi Obstetrics and Gynecology Hospital.
Results: The mean gestational age at the time of intervention was 29.05 ± 2.43 weeks. The study recorded that 100% of cases achieved target hemoglobin (Hb) levels after a single transfusion. The mean Middle Cerebral Artery Peak Systolic Velocity (MCA-PSV) decreased from 1.91 ± 0.14 MoM pre-intervention to 1.43 ± 0.08 MoM post-intervention. Following the procedure, 4/5 fetuses achieved prolonged survival. The mean gestational age at birth was 29 weeks 6 days ± 23.8 days. The mean 1-minute Apgar score was 5.8 ± 3.35. Poor prognostic factors included: early gestational age at transfusion, fetal hydrops, low pre-transfusion hemoglobin, high MCA-PSV, and the occurrence of procedure-related complications.
Conclusion: Intrauterine transfusion is an effective treatment that provides immediate improvement in fetal hematological and hemodynamic status, offering an opportunity to prolong the pregnancy. The results confirm the feasibility of this technique at a tertiary specialized facility while emphasizing the role of early detection and timely intervention before the progression to severe fetal hydrops.
Chi tiết bài viết
Từ khóa
Intrauterine transfusion, fetal anemia, fetal medicine.
Tài liệu tham khảo
[2] Liley AW. Intrauterine Transfusion of Foetus in Haemolytic Disease. Br Med J. 1963;2(5365):1107-1109.
[3] Zwiers C, Oepkes D, Lopriore E, Klumper FJ, de Haas M, van Kamp IL. The near disappearance of fetal hydrops in relation to current state‐of‐the‐art management of red cell alloimmunization. Prenat Diagn. 2018;38(12):943-950. doi:10.1002/pd.5355
[4] Picklesimer AH, Oepkes D, Moise KJ, et al. Determinants of the middle cerebral artery peak systolic velocity in the human fetus. Am J Obstet Gynecol. 2007;197(5): 526.e1-526.e4. doi: 10.1016/j.ajog.2007.04.002
[5] Enders, M., Weidner, A., Zoellner, I., Searle, K. and Enders, G. (2004), Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat. Diagn., 24: 513-518. https://doi.org/10.1002/pd.940
[6] Van Kamp, Inge L., et al. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. American Journal of Obstetrics & Gynecology, Volume 192, Issue 1, 171 – 177
[7] Cahen Peretz A, Tsaitlin-Mor L, Leibner G, et al. Late vs. early intrauterine blood transfusion in fetal anemia: impact on maternal and neonatal outcomes. Front Med (Lausanne). 2025 Sep 5;12:1614989. doi: 10.3389/fmed.2025.1614989.
[8] Blyth U, Larsson M, Baird A, et al. Neonatal outcomes following intrauterine transfusion for hemolytic disease of the fetus and newborn: a twenty-year service review. J Matern Fetal Neonatal Med. 2022 Dec;35(25):10220-10225. doi: 10.1080/14767058.2022.2122041. Epub 2022 Sep 18.
[9] Pares DBDS, Pacheco GHAS, Lobo GAR. Intrauterine Transfusion for Rhesus Alloimmunization: A Historical Retrospective Cohort from A Single Reference Center in Brazil. J Clin Med. 2024 Feb 28;13(5):1362. doi: 10.3390/jcm13051362.